What are Health Catalyst's total assets?

Health Catalyst (HCAT) holds $412.2M in total assets, down 53.8% year over year.

How much debt does Health Catalyst have?

Health Catalyst carries $170.6M in total debt against $138.1M of shareholders' equity, a debt-to-equity ratio of 1.23.

How much cash does Health Catalyst have?

Health Catalyst holds $59.9M in cash and equivalents.

Can Health Catalyst cover its short-term obligations?

Its current ratio is 1.69 — current assets exceed current liabilities.

Where does Health Catalyst's balance sheet data come from?

Every line is extracted from Health Catalyst's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Health Catalyst HCAT Balance Sheet Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Cash and cash equivalents	$50.81M-79.6%	$249.65M+135%	$106.28M-8.6%	$116.31M-39.8%
Short-term investments	$44.92M-68.4%	$142.36M-32.7%	$211.45M-14.5%	$247.18M-1.8%
Accounts receivable, net	$59.13M+3.4%	$57.18M-5.2%	$60.29M+25.7%	$47.97M-1.7%
Prepaid expenses and other current assets	$14.45M-12.3%	$16.47M+7.1%	$15.38M-5.9%	$16.34M+11.8%
Contract assets	$10.1M-14.4%	$11.8M+151%	$4.7M+422%	$900K+12.5%
Total current assets	$169.31M-63.6%	$465.65M+18.4%	$393.4M-8.0%	$427.8M-15.9%
Property and equipment, net	$33.84M+15.1%	$29.39M+14.3%	$25.71M-0.8%	$25.93M+11.2%
Accumulated depreciation	$53.33M+35.4%	$39.38M+44.0%	$27.36M+56.7%	$17.46M+52.7%
Operating lease right-of-use assets	$6.64M-44.9%	$12.06M-13.4%	$13.93M-16.4%	$16.66M-21.2%
Goodwill	$209.07M-19.5%	$259.76M+36.2%	$190.65M+2.5%	$185.98M+9.4%
Intangible assets, net	$77.68M-9.7%	$86.05M+17.3%	$73.38M-20.4%	$92.19M-12.0%
Other non-current assets	$2.4M-60.1%	$6.02M+26.9%	$4.74M+27.0%	$3.73M-16.9%
Available-for-sale securities	$89.98M-76.8%	$387.61M+24.5%	$311.23M-14.0%	$361.71M-15.8%
Total assets	$502.64M-41.5%	$858.93M+22.4%	$701.81M-6.7%	$752.29M-9.6%
Accounts payable	$9.36M-18.1%	$11.43M+72.2%	$6.64M+50.1%	$4.42M-5.7%
Accrued expenses	$5.2M-55.4%	$11.66M-0.2%	$11.68M-4.1%	$12.18M-30.1%
Deferred revenue	$56.11M+5.3%	$53.28M-4.4%	$55.75M+1.4%	$54.96M-3.0%
Current portion of long-term debt	$1.63M-99.3%	$231.18M—	$0—	——
Operating lease liabilities, current	$3.78M+4.6%	$3.61M+7.6%	$3.36M-2.2%	$3.43M+0.3%
Contract liabilities	$410K+64.7%	$249K+223%	$77K-26.7%	$105K-88.7%
Accrued interest	$3.38M-29.6%	$4.8M+434%	$900K+50.0%	$600K-25.0%
Total current liabilities	$89.57M-72.5%	$325.85M+266%	$89.03M+7.9%	$82.51M-11.3%
Long-term debt	$151.62M+0.3%	$151.18M-33.7%	$228.03M+0.7%	$226.52M+25.2%
Operating lease liabilities, non-current	$14.21M-12.8%	$16.29M-7.8%	$17.68M-1.9%	$18.02M-11.0%
Other non-current liabilities	$798K+418%	$154K+108%	$74K-38.8%	$121K+7.1%
Total liabilities	$256.86M-48.0%	$493.72M+47.4%	$334.9M+2.3%	$327.28M+5.6%
Preferred stock	$0—	$0—	$0—	$0—
Common stock	500M-67.8%	1.6B+4.6%	1.5B+4.2%	1.4B+1.7%
Retained earnings	-$1.36B-15.0%	-$1.19B-6.2%	-$1.12B-11.8%	-$999.02M-13.7%
Accumulated other comprehensive income (loss)	$1.59M+290%	-$835K-2,630%	$33K+105%	-$648K-867%
Total stockholders' equity	$245.78M-32.7%	$365.21M-0.5%	$366.92M-13.7%	$425.01M-18.6%
Total liabilities and stockholders' equity	$502.64M-41.5%	$858.93M+22.4%	$701.81M-6.7%	$752.29M-9.6%
Available-for-Sale Debt Securities - Amortized Cost	$89.93M-76.8%	$387.54M+24.6%	$311.14M-14.1%	$362.29M-15.7%
Allowance for Doubtful Accounts	$3.7M-11.9%	$4.2M+2.3%	$4.11M+78.5%	$2.3M+43.8%
Allowance for Doubtful Accounts Receivable (Current)	$3.7M-11.9%	$4.2M+2.3%	$4.11M+78.5%	$2.3M+43.8%
Capitalized Contract Costs, Current	$1.8M-14.3%	$2.1M-4.5%	$2.2M+46.7%	$1.5M+7.1%
Deferred costs	$1.8M-14.3%	$2.1M-4.5%	$2.2M+46.7%	$1.5M+7.1%
Capitalized Computer Software, Net	——	——	——	——
Deferred Tax Assets and Other Non-Current Assets	$6.11M+1.5%	$6.02M+26.9%	$4.74M+27.0%	$3.73M-16.9%
Finite Lived Intangible Assets - Gross	$275.88M+10.9%	$248.78M+19.9%	$207.49M+5.3%	$197.1M+13.1%
Net Investment in Lease	$6.64M-44.9%	$12.06M-13.4%	$13.93M-16.4%	$16.66M-21.2%
Capitalized software licenses	——	——	——	——
Deferred costs	$2.4M-17.2%	$2.9M-12.1%	$3.3M+26.9%	$2.6M-13.3%
Intangible assets — net	$77.68M-9.7%	$86.05M+17.3%	$73.38M-20.4%	$92.19M-12.0%
Other intangible assets—net	$77.68M-9.7%	$86.05M+17.3%	$73.38M-20.4%	$92.19M-12.0%
Operating lease right-of-use assets	$6.64M-44.9%	$12.06M-13.4%	$13.93M-16.4%	$16.66M-21.2%
Other non-current assets	$6.11M+1.5%	$6.02M+26.9%	$4.74M+27.0%	$3.73M-16.9%
Property, plant and equipment at cost	$87.16M+26.7%	$68.78M+29.6%	$53.07M+22.3%	$43.39M+24.9%
Short-term investment securities (includes restricted investments of consolidated variable interest entities: 2026, $85; 2025, $84)	$44.92M-68.4%	$142.36M-32.7%	$211.45M-14.5%	$247.18M-1.8%
Operating Lease Right-of-Use Assets in Other Assets	$6.64M-44.9%	$12.06M-13.4%	$13.93M-16.4%	$16.66M-21.2%
Software and Technology Licenses, Net	$6.11M+1.5%	$6.02M+26.9%	$4.74M+27.0%	$3.73M-16.9%
Accrued Manufacturing Costs	$5.2M-55.4%	$11.66M-0.2%	$11.68M-4.1%	$12.18M-30.1%
Accrued Progress Collections and Price Adjustments	$410K+64.7%	$249K+223%	$77K-26.7%	$105K-88.7%
Accrued Liabilities And Employee-Related Liabilities, Current	$18.7M-29.0%	$26.34M+13.1%	$23.28M+18.2%	$19.69M-17.0%
Compensation and benefits	$5.2M-55.4%	$11.66M-0.2%	$11.68M-4.1%	$12.18M-30.1%
Restructuring Reserve	$704K—	$0-100%	$2.36M+28.2%	$1.84M—
Contingent Consideration Liability (Non-Current)	$250K—	$0—	——	$0-100%
Contract Liabilities, Non-Current	$410K+64.7%	$249K+223%	$77K-26.7%	$105K-88.7%
Debt Maturity - 2024	——	——	——	——
Debt Maturity - 2027	——	——	——	——
Debt - Unamortized Discount (Premium) and Issuance Costs, Net	$7.51M-25.1%	$10.03M+410%	$1.97M—	——
Deferred revenue, net of current portion	$410K+64.7%	$249K+223%	$77K-26.7%	$105K-88.7%
Total debt	$171.24M-57.4%	$402.27M+61.5%	$249.07M+0.4%	$247.97M+21.2%
Total Carrying Value of Debt	$160.76M-59.0%	$392.39M+70.6%	$230M—	——
Common Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Common Stock Shares Authorized	72.1M+12.6%	64M+9.4%	58.5M+5.0%	55.8M+5.8%
Common Stock Shares Issued	72.1M+12.6%	64M+9.4%	58.5M+2.0%	57.4M+4.8%
Common Stock Shares Outstanding	——	——	——	——
Convertible Preferred Stock Authorized Shares	25M0.0%	25M0.0%	25M0.0%	25M0.0%
Convertible Preferred Stock Issued Shares	0—	0—	0—	0—
Convertible Preferred Stock Outstanding Shares	0—	0—	0—	0—
Common stock	$1.61B+3.6%	$1.55B+4.6%	$1.48B+4.2%	$1.42B+1.7%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding	$0—	$0—	$0—	$0—
Number of Exercisable Options	——	——	——	——
Number of Vested and Expected to Vest Options	——	——	——	——
Preferred Stock Par Value Per Share	$0.000.0%	$0.000.0%	$0.000.0%	$0.000.0%
Share-Based Payment Award Options Outstanding - Number	842.1K-20.0%	1.1M-24.6%	1.4M-20.1%	1.7M-17.4%
Unrealized Gains on Investments	$47K-36.5%	$74K-36.8%	$117K+1,363%	$8K—
Unrealized Losses on Investments (Before Tax)	$0—	$0-100%	$30K-94.9%	$583K+563%
Weighted Average Exercise Price of Outstanding Options	$12.36+3.1%	$11.99+2.5%	$11.70+1.7%	$11.51+0.5%
Weighted Average Exercise Price of Vested and Expected to Vest Options	——	——	——	——
Cumulative Cost Basis	$87.16M+26.7%	$68.78M+29.6%	$53.07M+22.3%	$43.39M+24.9%
Deferred Revenue Timing Percentage	——	——	——	——
Fair Value Measurement Disclosure	$89.73M—	——	——	——
Accounts Receivable, Allowance for Credit Loss	$3.7M-11.9%	$4.2M+2.3%	$4.11M+78.5%	$2.3M+43.8%
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax	$0—	$0-100%	$30K-94.9%	$583K+563%
Gross Unrealized Gains	$47K-36.5%	$74K-36.8%	$117K+1,363%	$8K—
Business Combination, Contingent Consideration, Liability	$250K—	——	——	——
Common stock, par value (in dollars per share)	$00.0%	$00.0%	$00.0%	$00.0%
Common stock, shares authorized (in shares)	$500M0.0%	$500M0.0%	$500M0.0%	$500M0.0%
Common stock, shares issued (in shares)	$72.03M+12.5%	$64.04M+9.9%	$58.3M+5.5%	$55.26M+5.0%
Common Stock, Shares, Outstanding	$72.03M+12.5%	$64.04M+9.9%	$58.3M+5.5%	$55.26M+5.0%
Contract with Customer, Liability	$56.5M+5.6%	$53.5M-4.1%	$55.8M+1.3%	$55.1M-4.3%
Long-term debt, gross	$160.76M-59.0%	$392.39M+70.6%	$230M—	——
Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net	$7.51M-25.1%	$10.03M+410%	$1.97M—	——
Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss	$89.93M-76.8%	$387.54M+24.6%	$311.14M-14.1%	$362.29M-15.7%
Estimated Fair Value	$89.98M-76.8%	$387.61M+24.5%	$311.23M-14.0%	$361.71M-15.8%
Finite-Lived Intangible Assets, Accumulated Amortization	$198.2M+21.8%	$162.72M+21.3%	$134.11M+27.8%	$104.92M+50.9%
Gross Carrying Amount	$275.88M+10.9%	$248.78M+19.9%	$207.49M+5.3%	$197.1M+13.1%
Goodwill, Gross	$6.7M—	——	——	——
2028	——	——	——	——
2029	——	——	——	——
2027	——	——	——	——
Remainder of 2026	——	——	——	——
Other accrued liabilities	$9.41M-4.8%	$9.88M+6.9%	$9.25M+63.0%	$5.67M-9.9%
Preferred Stock, Par or Stated Value Per Share	$00.0%	$00.0%	$00.0%	$00.0%
Preferred Stock, Shares Authorized	$25M0.0%	$25M0.0%	$25M0.0%	$25M0.0%
Preferred Stock, Shares Issued	$0—	$0—	$0—	$0—
Preferred Stock, Shares Outstanding	$0—	$0—	$0—	$0—
Severance accrual, current	$704K—	$0-100%	$2.36M+28.2%	$1.84M—
Remaining performance obligations related to customer contracts that are unsatisfied or partially unsatisfied	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price	——	——	——	——
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number	$842.09K-20.0%	$1.05M-24.6%	$1.4M-20.1%	$1.75M-17.4%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number	——	——	——	——
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$12.36+3.1%	$11.99+2.5%	$11.7+1.7%	$11.51+0.5%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value	——	——	——	——
Shares, Issued	$72.13M+12.6%	$64.04M+9.4%	$58.53M+2.0%	$57.37M+4.8%
Shares, Outstanding	$72.13M+12.6%	$64.04M+9.4%	$58.53M+5.0%	$55.76M+5.8%
Stockholders vote	——	——	——	——
Remainder of Fiscal Year 2024	——	——	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Health Catalyst.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Health Catalyst's total assets?: Health Catalyst (HCAT) holds $412.2M in total assets, down 53.8% year over year.
How much debt does Health Catalyst have?: Health Catalyst carries $170.6M in total debt against $138.1M of shareholders' equity, a debt-to-equity ratio of 1.23.
How much cash does Health Catalyst have?: Health Catalyst holds $59.9M in cash and equivalents.
Can Health Catalyst cover its short-term obligations?: Its current ratio is 1.69 — current assets exceed current liabilities.
Where does Health Catalyst's balance sheet data come from?: Every line is extracted from Health Catalyst's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.